Ignite Creation Date:
2025-12-24 @ 4:04 PM
Ignite Modification Date:
2026-01-05 @ 1:35 PM
Study NCT ID:
NCT05838066
Status:
RECRUITING
Last Update Posted:
2025-05-30
First Post:
2023-04-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of KN026 in Combination With HB1801 in the First-line Treatment of Subjects With HER2-positive Recurrent or Metastatic Breast Cancer.
Sponsor:
Shanghai JMT-Bio Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-20
First Submit QC Date:
None
Study First Post Date:
2023-05-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-26
Last Update Post Date:
2025-05-30
Last Update Post Date Type:
ACTUAL